[go: up one dir, main page]

AU2002224337A1 - Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery - Google Patents

Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery

Info

Publication number
AU2002224337A1
AU2002224337A1 AU2002224337A AU2433702A AU2002224337A1 AU 2002224337 A1 AU2002224337 A1 AU 2002224337A1 AU 2002224337 A AU2002224337 A AU 2002224337A AU 2433702 A AU2433702 A AU 2433702A AU 2002224337 A1 AU2002224337 A1 AU 2002224337A1
Authority
AU
Australia
Prior art keywords
acid derivatives
refractive surgery
following refractive
hydroperoxyeicosatetraenoic acid
derivatives following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224337A
Other languages
English (en)
Inventor
Daniel A Gamache
Steven T. Miller
John M Yanni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Universal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Universal Ltd filed Critical Alcon Universal Ltd
Publication of AU2002224337A1 publication Critical patent/AU2002224337A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002224337A 2000-10-23 2001-09-27 Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery Abandoned AU2002224337A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24264200P 2000-10-23 2000-10-23
US60/242,642 2000-10-23
PCT/US2001/030201 WO2002034246A2 (fr) 2000-10-23 2001-09-27 Utilisation de derives d'acide hydroxyeicosatetranoique (hete) apres une chirurgie refractive

Publications (1)

Publication Number Publication Date
AU2002224337A1 true AU2002224337A1 (en) 2002-05-06

Family

ID=22915610

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224337A Abandoned AU2002224337A1 (en) 2000-10-23 2001-09-27 Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery

Country Status (4)

Country Link
US (1) US20020077358A1 (fr)
AR (1) AR030879A1 (fr)
AU (1) AU2002224337A1 (fr)
WO (1) WO2002034246A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030894A1 (fr) * 2001-10-11 2003-04-17 Alcon, Inc. Methodes de traitement des yeux secs
EP1583527A1 (fr) * 2002-06-14 2005-10-12 Alcon, Inc. Utilisation de composes d'acide hydroxyeicosatetraenoique pour traiter des troubles inflammatoires ophtalmiques
GB0426264D0 (en) * 2004-11-30 2004-12-29 Trigen Ltd Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
CN1114401C (zh) * 1998-07-14 2003-07-16 阿尔康实验室公司 11-(3-二甲氨基亚丙基)-6,11-二氢二苯并[b,e]噁庚英-2-乙酸用于制药的新用途
BR0015416A (pt) * 1999-11-09 2002-07-16 Alcon Inc Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
TR200201250T2 (tr) * 1999-11-09 2002-09-23 Alcon, Inc Hidroksieikosatetraenoat tuzları, bileşimleri ve bunların göz kuruması bozukluklarının iyileştirilmesinde kullanım yöntemleri.

Also Published As

Publication number Publication date
US20020077358A1 (en) 2002-06-20
WO2002034246A3 (fr) 2003-10-09
WO2002034246A2 (fr) 2002-05-02
AR030879A1 (es) 2003-09-03

Similar Documents

Publication Publication Date Title
AU2001269046A1 (en) Use of therapeutic benzamide derivatives
AU2001294515A1 (en) Use of stat-6 inhibitors as therapeutic agents
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2002241520A1 (en) Blood assessment of injury
AU2002334969A1 (en) Use of stat-6 inhibitors as therapeutic agents
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2001288577A1 (en) Laser polishing of medical devices
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2002339991A1 (en) Use of hif-1alpha variants to accelerate wound healing
AU2001235437A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
AU2001255796A1 (en) (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2001284763A1 (en) Preparation of risperidone
AU2002224337A1 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU2001274344A1 (en) Tissue inhibitors of matrix metalloproteinases
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001257253A1 (en) Asymmetric synthesis of piperazic acid and derivatives thereof
AU2001245092A1 (en) Sterilization of elongate lumens
AU2001264375A1 (en) Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
AU2001287897A1 (en) Manipulation of spermatozoa
AU2002355739A1 (en) Preparation and use of alpha-keto phosphonates
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
AU2002215923A1 (en) Use of medicaments
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors